• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Microbiome and metabolic disorder in prolactinoma: intrinsic gender differences and extrinsic therapy effects.

作者信息

Ye Zhen, Yu Yifei, Cao Zhan, Ye Zhao, Gu Xufang, Shen Xiaoxu, Cai Boyu, Lin Ben, Ji Chenxing, Qiao Nidan, Wu Zerui, Chen Zhengyuan, Ma Zengyi, Chen Long, Liang Buqing, Liao Yankai, He Wenqiang, Shen Qing, Han Jiaxin, Cao Xiaoyun, Zhou Xiang, Shou Xuefei, Shen Ming, Wang Yongfei, Zhang Zhaoyun, Ye Hongying, Zhang Qilin, Gao Renyuan, Zhang Yichao

机构信息

Department of Neurosurgery, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, China.

Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, China.

出版信息

Pituitary. 2025 Jul 3;28(4):83. doi: 10.1007/s11102-025-01544-x.

DOI:10.1007/s11102-025-01544-x
PMID:40608175
Abstract
摘要

相似文献

1
Microbiome and metabolic disorder in prolactinoma: intrinsic gender differences and extrinsic therapy effects.泌乳素瘤中的微生物群与代谢紊乱：内在性别差异及外在治疗效果
Pituitary. 2025 Jul 3;28(4):83. doi: 10.1007/s11102-025-01544-x.
2
Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis.卡麦角林治疗的泌乳素瘤患者当前的药物撤药策略：一项系统评价和荟萃分析。
Pituitary. 2015 Oct;18(5):745-51. doi: 10.1007/s11102-014-0617-2.
3
Update on the withdrawal of dopamine agonists in patients with hyperprolactinemia.高泌乳素血症患者多巴胺激动剂停药的最新进展。
Curr Opin Endocrinol Diabetes Obes. 2011 Aug;18(4):264-8. doi: 10.1097/MED.0b013e328347c94a.
4
Giant prolactinomas, a detailed analysis of 196 adult cases.巨大泌乳素腺瘤：196 例成人病例的详细分析。
Pituitary. 2023 Oct;26(5):529-537. doi: 10.1007/s11102-023-01337-0. Epub 2023 Aug 7.
5
Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis.多巴胺激动剂停药后高泌乳素血症的复发：系统评价和荟萃分析。
J Clin Endocrinol Metab. 2010 Jan;95(1):43-51. doi: 10.1210/jc.2009-1238. Epub 2009 Oct 30.
6
Different Cabergoline Effect on Metabolic and Anthropometric Parameters in Female Prolactinoma Patients Versus Idiopathic Hyperprolactinemia Patients.卡麦角林对女性泌乳素瘤患者与特发性高泌乳素血症患者代谢和人体测量参数的不同影响。
Endocr Metab Immune Disord Drug Targets. 2019;19(4):511-518. doi: 10.2174/1871530319666190219103812.
7
Osteoporotic fractures in patients with untreated hyperprolactinemia vs. those taking dopamine agonists: A systematic review and meta-analysis.未经治疗的高泌乳素血症患者与服用多巴胺激动剂患者的骨质疏松性骨折：一项系统评价和荟萃分析。
Neuro Endocrinol Lett. 2015;36(8):745-9.
8
Optimal timing of dopamine agonist withdrawal in patients with hyperprolactinemia: a systematic review and meta-analysis.高泌乳素血症患者多巴胺激动剂停药的最佳时机：系统评价和荟萃分析。
Endocrine. 2018 Jan;59(1):50-61. doi: 10.1007/s12020-017-1444-9. Epub 2017 Oct 17.
9
Cabergoline monotherapy in polycystic ovary syndrome patients with elevated prolactin: a viable option?卡麦角林单药治疗高催乳素血症的多囊卵巢综合征患者：一个可行的选择？
Endocrine. 2025 May 21. doi: 10.1007/s12020-025-04279-8.
10
Mendelian randomization study revealed a gut microbiota-immune system-kidney junction axis in chronic kidney disease.孟德尔随机化研究揭示了慢性肾脏病中肠道微生物群-免疫系统-肾脏连接轴。
Sci Rep. 2025 Jul 1;15(1):21685. doi: 10.1038/s41598-025-05941-x.

本文引用的文献

1
Concomitant gut dysbiosis and defective gut barrier serve as the bridges between hypercortisolism and chronic systemic inflammation in Cushing's disease.库欣病中皮质醇过度症与慢性系统性炎症之间的桥梁是肠道菌群失调和肠道屏障功能缺陷。
Eur J Endocrinol. 2024 Oct 29;191(5):509-522. doi: 10.1093/ejendo/lvae139.
2
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly.肢端肥大症患者口腔和粪便微生物群的综合评估。
Pituitary. 2024 Oct;27(5):555-566. doi: 10.1007/s11102-024-01444-6. Epub 2024 Aug 19.
3
Exploring causal effects of gut microbiota and metabolites on body fat percentage using two-sample Mendelian randomization.
采用两样本孟德尔随机化方法探究肠道微生物群和代谢产物对体脂肪百分比的因果效应。
Diabetes Obes Metab. 2024 Sep;26(9):3541-3551. doi: 10.1111/dom.15692. Epub 2024 Jun 3.
4
Gut microbiota and risk of endocarditis: a bidirectional Mendelian randomization study.肠道微生物群与心内膜炎风险：一项双向孟德尔随机化研究。
Front Microbiol. 2024 Jan 17;15:1320095. doi: 10.3389/fmicb.2024.1320095. eCollection 2024.
5
Sequential appetite suppression by oral and visceral feedback to the brainstem.通过口腔和内脏向脑干的反馈实现食欲的序贯抑制。
Nature. 2023 Dec;624(7990):130-137. doi: 10.1038/s41586-023-06758-2. Epub 2023 Nov 22.
6
The Diversity of Gut Microbiota at Weaning Is Altered in Prolactin Receptor-Null Mice.断奶期肠道微生物组的多样性在催乳素受体缺失小鼠中发生改变。
Nutrients. 2023 Aug 4;15(15):3447. doi: 10.3390/nu15153447.
7
Bifidobacterium adolescentis induces Decorin macrophages via TLR2 to suppress colorectal carcinogenesis.青春双歧杆菌通过 TLR2 诱导 Decorin 巨噬细胞抑制结直肠肿瘤发生。
J Exp Clin Cancer Res. 2023 Jul 18;42(1):172. doi: 10.1186/s13046-023-02746-6.
8
-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis.源自短链脂肪酸和吲哚化合物通过调节肠-肝轴减轻非酒精性脂肪性肝病。
Front Microbiol. 2023 Mar 1;14:1129904. doi: 10.3389/fmicb.2023.1129904. eCollection 2023.
9
Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases.血浆代谢组学基因组图谱优先考虑与人类疾病相关的代谢物。
Nat Genet. 2023 Jan;55(1):44-53. doi: 10.1038/s41588-022-01270-1. Epub 2023 Jan 12.
10
Ruminal bacteria lipopolysaccharides: an immunological and microbial outlook.瘤胃细菌脂多糖：免疫学与微生物学视角
J Anim Sci Biotechnol. 2022 Apr 14;13(1):41. doi: 10.1186/s40104-022-00692-5.